SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Dynogen Pharmaceuticals, Inc.'s Prokinetic Drug, DDP733, Enters Phase 2b for Irritable Bowel Syndrome with Constipation